Pharma Foods International Co., Ltd.
2929・Prime Market・Foods
Governance
Company with a Board of Corporate Auditors. The Board of Directors consists of 8 members (3 outside directors, outside director ratio 37.5%), and the Board of Corporate Auditors consists of 4 members (2 outside auditors). The Board of Directors meets 20 times per year. The company has established a Nomination and Compensation Committee (with independent outside directors forming a majority) and a Risk and Compliance Committee (chaired by an independent outside director) to strengthen governance functions. Following approval at the Annual General Meeting of Shareholders on October 24, 2025, the Board of Directors is expected to consist of 10 members (4 outside directors).
Risk Management
The company has established a Risk and Compliance Committee chaired by an independent outside director, promoting company-wide risk management and thorough compliance. For climate change-related risks, a framework has been put in place whereby the Corporate Planning Department identifies and assesses such risks, which are then submitted to and overseen by the Board of Directors via the committee. Individual risk management regulations have also been established for matters such as fund management and research and development.
Shareholder Returns
Dividends are paid twice a year. For FY2026 (ending July 2026), the company will maintain an annual dividend of ¥25 per share (interim ¥12.5 plus year-end ¥12.5 planned). No revision has been made to the dividend forecast.
Dividend Policy
The basic policy is to pay dividends twice a year (interim and year-end). The actual dividend for FY2025 (ended July 2025) was an annual total of ¥25 per share (interim ¥12.5 plus year-end ¥12.5). For FY2026 (ending July 2026), the same annual total of ¥25 per share (interim ¥12.5 plus year-end ¥12.5) is planned, with no revision from the most recently announced dividend forecast. Separately, based on a resolution of the Board of Directors held on November 17, 2025, the company disposed of 228,576 treasury shares as restricted stock compensation, leaving a treasury share balance of ¥26 million (35,623 shares) at the end of the third quarter under review.
ESG
The company conducted TCFD-aligned 1.5°C and 4°C scenario analyses to identify transition risks, physical risks, and opportunities. It has designated the upcycling of underutilized resources such as eggshell membrane as a key sustainability priority, and regularly measures Scope 1 and Scope 2 GHG emissions (reduction targets to be set going forward). In terms of human capital, it has set numerical targets—with a deadline of July 2026—for the ratio of female managers, the male childcare leave uptake rate, and the gender pay gap, while promoting diversity management and health management.
Last updated: October 21, 2025